Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...
For those sniffling, sneezing, stuffy head symptoms lurking right around the corner, see whether your preferred medicine will ...
The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...
On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...
The FDA had proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold ...
Avadel Pharmaceuticals plc AVDL announced that the FDA has approved its supplemental new drug application (sNDA) seeking label expansion of Lumryz. The drug is now approved in the United States ...
The U.S. Food and Drug Administration ( FDA) has classified the recall of a brand of ice cream as Class II after it was discovered that the product contained undeclared food colorings Yellow 5 ...
FDA clearance of HG202 marks a significant milestone for CRISPR ... The BRIGHT trial is a phase 1, open-label, ...
Information about nitrosamine impurities in medications. National Library of Medicine: DailyMed. Cymbalta—duloxetine hydrochloride capsule, delayed release [drug label].
There have been signs that the FDA is considering regulatory action, too. In 2023, the agency issued a request for information on food labeling in online grocery shopping, citing previous research ...